Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Dutasteride may help shrink prostate cancer tumors.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Cancer survivors need better skin care to improve their quality of life.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Structured prevention strategies and Brain Health Clinics can help prevent Alzheimer's.

Extracts improve hair growth in alopecia.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Minoxidil modestly increases hair growth in men with early baldness and is safe to use.

Breast cancer alters specific molecular structures in hair, which revert after cancer removal.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Intense exercise at night can delay the body's internal clock gene expression by 2 to 4 hours.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.